| David Grant Baer, MD | |
|
227 Hospital Dr, Suite 1, Everett, PA 15537-7019 | |
| (412) 623-9095 | |
| Not Available |
| Full Name | David Grant Baer |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 45 Years |
| Location | 227 Hospital Dr, Everett, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194797167 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD024184E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Upmc Home Healthcare Of Central Pennsylvania | Altoona, PA | Home health agency |
| Conemaugh Home Health | Johnstown, PA | Home health agency |
| Family Hospice And Palliative Care | Altoona, PA | Hospice |
| Southerncare Altoona | Altoona, PA | Hospice |
| Upmc Bedford Memorial | Everett, PA | Hospital |
| Upmc Altoona | Altoona, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Upmc Community Medicine Inc | 2062318975 | 690 |
News Archive
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.
Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.
Investigators at the Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide-which causes a chemical reaction called S-nitrosylation-mediates neurodegeneration associated with Alzheimer's disease.
› Verified 9 days ago
| Entity Name | Upmc Community Medicine Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1558976092 PECOS PAC ID: 2062318975 Enrollment ID: O20040217000388 |
News Archive
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.
Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.
Investigators at the Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide-which causes a chemical reaction called S-nitrosylation-mediates neurodegeneration associated with Alzheimer's disease.
› Verified 9 days ago
| Entity Name | Upmc Altoona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487604179 PECOS PAC ID: 8426962465 Enrollment ID: O20040406001053 |
News Archive
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.
Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.
Investigators at the Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide-which causes a chemical reaction called S-nitrosylation-mediates neurodegeneration associated with Alzheimer's disease.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Grant Baer, MD 227 Hospital Dr, Suite 1, Everett, PA 15537-7019 Ph: () - | David Grant Baer, MD 227 Hospital Dr, Suite 1, Everett, PA 15537-7019 Ph: (412) 623-9095 |
News Archive
Porvair Sciences has introduced a new range of pierceable cap mats from sister company, JG Finneran Associates Inc. These new cap mats ensure the integrity of samples in Porvair 96-well Deep well microplate with glass inserts used in high throughput chromatography.
The U.S. CDC reports the observed efficacy among the immunocompromised population following vaccination with mRNA vaccines against SARS-CoV-2.
Genocea Biosciences, a vaccine discovery and development company, today announced an exclusive worldwide license for developed countries to a portfolio of Streptococcus pneumoniae antigens from Children's Hospital Boston. PATH and Genocea retain certain co-exclusive rights to the antigens for use in developing countries under their collaboration agreements with Children's Hospital Boston.
Investigators at the Burnham Institute for Medical Research (Burnham) have demonstrated that attacks on the mitochondrial protein Drp1 by the free radical nitric oxide-which causes a chemical reaction called S-nitrosylation-mediates neurodegeneration associated with Alzheimer's disease.
› Verified 9 days ago
Dr. George Edward Fleming Jr., MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10455 Lincoln Hwy, Everett, PA 15537 Phone: 814-623-6161 | |
Dr. Flora Macalintal Torres, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 220 W Main St, Everett, PA 15537 Phone: 814-652-6107 | |
Dr. David James Horton, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 10455 Lincoln Hwy, Everett, PA 15537 Phone: 814-623-3500 |